Advertisement

Topics

Axonics Granted Four U.S. Patents Related to its Implantable Sacral Neuromodulation Technology

11:00 EST 23 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Axonics Modulation Technologies, Inc., developer of the first rechargeable Sacral Neuromodulation (r-SNM™) system for the treatment of urinary and fecal dysfunction, announced today that the United States Patent and Trademark ...

Other Sources for this Article

Pure Communications, Inc.
Media & Investor Contact
Matt Clawson, +1 949-370-8500
mclawson@purecommunications.com

NEXT ARTICLE

More From BioPortfolio on "Axonics Granted Four U.S. Patents Related to its Implantable Sacral Neuromodulation Technology"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Urology
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...